AVIDITY PARTNERS MANAGEMENT LP
Adviser information for AVIDITY PARTNERS MANAGEMENT LP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Partnership |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 23 |
|---|---|
| Investment Advisory/Research | 16 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | Yes |
|---|
| Type | Accounts | RAUM |
|---|---|---|
| Discretionary | 10 | $5.3B |
| Non-Discretionary | 0 | $0 |
| Total | 10 | $5.3B |
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 10 | $5.3B |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 60 |
Services
| Advisory Services | Portfolio management for pooled investment vehicles |
|---|---|
| Compensation | % of AUMPerformance-based fees |
Principal Office
2828 N. HARWOOD ST., SUITE 1220DALLAS
TX
United States
Monday - Friday, 8AM-5PM
Tel: 214-550-1822, Fax: None
Chief Compliance Officer
DELMER DEE RAIBOURN III
2828 N. HARWOOD ST., SUITE 1220
DALLAS
TX
United States
Tel:
214-550-1934
D***********@******************M
(Full email address available in API data)
Regulatory Contact
DANIEL RODRIGUEZ
DEPUTY CHIEF COMPLIANCE OFFICER
165 MASON ST., FLOOR 2
GREENWICH
CT
United States
Tel:
475-465-0267
D***************@******************M
(Full email address available in API data)
Industry Affiliates
| AVIDITY CAPITAL PARTNERS FUND (GP) LP | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| AVIDITY CAPITAL FUND II LP | Hedge Fund | $38.4M | $5.0M | 10 |
| AVIDITY MASTER FUND III LP | Hedge Fund | $30.0M | $5.0M | 4 |
| AVIDITY MASTER FUND LP | Hedge Fund | $4,788.7M | $5.0M | 166 |
| AVIDITY PRIVATE MASTER FUND I LP | Hedge Fund | $411.8M | $10.0M | 18 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| GANDY, JARED, ALLAN | Individual | – | CHIEF FINANCIAL OFFICER | 04/2019 | < 5% |
| WITZKE, DAVID, ROY | Individual | – | CO-MANAGING PARTNER, PORTFOLIO MANAGER, CHIEF INVESTMENT OFFICER | 04/2019 | 25-50% |
| GREGORY, MICHAEL, DAVID | Individual | – | CO-MANAGING PARTNER, DIRECTOR OF RESEARCH, PRESIDENT OF BUSINESS OPERATIONS | 04/2019 | 25-50% |
| AVIDITY PARTNERS MANAGEMENT (GP) LLC | Domestic Entity | – | GENERAL PARTNER | 04/2019 | < 5% |
| WITZKE, DAVID, ROY | Individual | AVIDITY PARTNERS MANAGEMENT (GP) LLC | MANAGING MEMBER | 04/2019 | 25-50% |
| GREGORY, MICHAEL, DAVID | Individual | AVIDITY PARTNERS MANAGEMENT (GP) LLC | MANAGING MEMBER | 04/2019 | 25-50% |
| WITZKE AVIDITY TRUST | Domestic Entity | – | LIMITED PARTNER | 10/2019 | 10-25% |
| GREGORY AVIDITY TRUST | Domestic Entity | – | LIMITED PARTNER | 10/2019 | 10-25% |
| WITZKE, DAVID, ROY | Individual | WITZKE AVIDITY TRUST | TRUSTEE | 10/2019 | |
| GREGORY, MICHAEL, DAVID | Individual | GREGORY AVIDITY TRUST | TRUSTEE | 10/2019 | |
| RAIBOURN, DELMER, DEE | Individual | – | CHIEF COMPLIANCE OFFICER | 07/2022 | < 5% |
| So, Andrew, Chee Wai | Individual | – | GENERAL COUNSEL | 05/2021 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| ABBVIE INC | COM | 48M | 278K | – |
| AC IMMUNE SA | SHS | 3M | 825K | – |
| ACADIA HEALTHCARE COMPANY IN | COM | 76M | 1M | – |
| ALNYLAM PHARMACEUTICALS INC | COM | 54M | 222K | – |
| APOGEE THERAPEUTICS INC | COM | 19M | 487K | – |
| ARCA BIOPHARMA INC | COM | 4M | 1M | – |
| ARGENX SE | SPONSORED ADR | 26M | 61K | – |
| ARVINAS INC | COM | 80M | 3M | – |
| ASTRAZENECA PLC | SPONSORED ADR | 16M | 205K | – |
| AVANTOR INC | COM | 65M | 3M | – |
| AXSOME THERAPEUTICS INC | COM | 30M | 376K | – |
| BIOHAVEN LTD | COM | 16M | 450K | – |
| BLUEPRINT MEDICINES CORP | COM | 41M | 383K | – |
| BOSTON SCIENTIFIC CORP | COM | 90M | 1M | – |
| CAREMAX INC | CL A NEW | 59K | 21K | – |
| CG ONCOLOGY INC | COM | 41M | 1M | – |
| COGENT BIOSCIENCES INC | COM | 8M | 1M | – |
| COLLEGIUM PHARMACEUTICAL INC | COM | 4M | 117K | – |
| CONTEXT THERAPEUTICS INC | COM | 15M | 7M | – |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 10M | 216K | – |
| CULLINAN THERAPEUTICS INC | COM | 27M | 2M | – |
| CYBIN INC | COM | 9M | 35M | – |
| DANAHER CORPORATION | COM | 37M | 150K | – |
| DEXCOM INC | COM | 29M | 259K | – |
| DIANTHUS THERAPEUTICS INC | COM | 75M | 3M | – |
| EDITAS MEDICINE INC | COM | 4M | 816K | – |
| ESTABLISHMENT LABS HLDGS INC | COM | 24M | 531K | – |
| EXACT SCIENCES CORP | COM | 14M | 339K | – |
| GILEAD SCIENCES INC | COM | 17M | 255K | – |
| GLAUKOS CORP | COM | 27M | 224K | – |
| HYPERFINE INC | COM CL A | 1M | 1M | – |
| IDEAYA BIOSCIENCES INC | COM | 39M | 1M | – |
| ILLUMINA INC | COM | 50M | 478K | – |
| IMMATICS N.V | SHS | 5M | 393K | – |
| IMMUNIC INC | COM | 10M | 9M | – |
| IMMUNOCORE HLDGS PLC | ADS | 7M | 200K | – |
| IMMUNOME INC | COM | 11M | 874K | – |
| IMMUNOVANT INC | COM | 24M | 908K | – |
| INCYTE CORP | COM | 32M | 529K | – |
| INSMED INC | COM PAR $.01 | 29M | 430K | – |
| INTELLIA THERAPEUTICS INC | COM | 4M | 170K | – |
| INTRA-CELLULAR THERAPIES INC | COM | 27M | 400K | – |
| INTUITIVE SURGICAL INC | COM NEW | 109M | 245K | – |
| IONIS PHARMACEUTICALS INC | COM | 4M | 93K | – |
| JANUX THERAPEUTICS INC | COM | 35M | 840K | – |
| JASPER THERAPEUTICS INC | COM NEW | 18M | 782K | – |
| JAZZ PHARMACEUTICALS PLC | SHS USD | 58M | 545K | – |
| KARYOPHARM THERAPEUTICS INC | COM | 2M | 2M | – |
| KEROS THERAPEUTICS INC | COM | 16M | 343K | – |
| KEZAR LIFE SCIENCES INC | COM | 3M | 5M | – |
| LANTHEUS HLDGS INC | COM | 23M | 290K | – |
| LEGEND BIOTECH CORP | SPONSORED ADS | 18M | 398K | – |
| MERCK & CO INC | COM | 40M | 325K | – |
| MIRUM PHARMACEUTICALS INC | COM | 25M | 731K | – |
| NATERA INC | COM | 83M | 767K | – |
| NEUMORA THERAPEUTICS INC. | COM | 18M | 2M | – |
| NEUROCRINE BIOSCIENCES INC | COM | 68M | 491K | – |
| NEUROGENE INC | COM | 26M | 728K | – |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | 11M | 559K | – |
| NUVATION BIO INC | *W EXP 07/07/202 | 2K | 12K | – |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 30M | 3M | – |
| PHATHOM PHARMACEUTICALS INC | COM | 17M | 2M | – |
| PRIME MEDICINE INC | COM | 4M | 694K | – |
| PRIVIA HEALTH GROUP INC | COM | 13M | 764K | – |
| REGENERON PHARMACEUTICALS | COM | 50M | 48K | – |
| REGENXBIO INC | COM | 15M | 1M | – |
| REVOLUTION MEDICINES INC | COM | 29M | 755K | – |
| ROCKET PHARMACEUTICALS INC | COM | 24M | 1M | – |
| SANOFI | SPONSORED ADR | 15M | 315K | – |
| SCYNEXIS INC | COM NEW | 3M | 1M | – |
| SPYRE THERAPEUTICS INC | COM NEW | 5M | 195K | – |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 42M | 1M | – |
| SURGERY PARTNERS INC | COM | 31M | 1M | – |
| SYNDAX PHARMACEUTICALS INC | COM | 68M | 3M | – |
| SYROS PHARMACEUTICALS INC | COM NEW | 9M | 2M | – |
| TENET HEALTHCARE CORP | COM NEW | 49M | 372K | – |
| THE CIGNA GROUP | COM | 61M | 185K | – |
| THERMO FISHER SCIENTIFIC INC | COM | 44M | 80K | – |
| TYRA BIOSCIENCES INC | COM | 6M | 373K | – |
| UIPATH INC | CL A | 5M | 362K | – |
| ULTRAGENYX PHARMACEUTICAL IN | COM | 39M | 960K | – |
| UNITED THERAPEUTICS CORP DEL | COM | 35M | 110K | – |
| VAXCYTE INC | COM | 21M | 284K | – |
| WAVE LIFE SCIENCES LTD | SHS | 2M | 350K | – |
| XENON PHARMACEUTICALS INC | COM | 29M | 754K | – |